|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current assets | ||||||||
| Cash | ||||||||
| Prepaid expenses | ||||||||
| Total current assets | ||||||||
| Cash and investments held in Trust Account | ||||||||
| TOTAL ASSETS | ||||||||
| Current liabilities | ||||||||
| Accrued expenses | ||||||||
| Due to related party | ||||||||
| Convertible Promissory note – related party | ||||||||
| Advance from related party | ||||||||
| Promissory note - related party | ||||||||
| Income taxes payable | ||||||||
| Total current liabilities | ||||||||
| Convertible related party loans | ||||||||
| Warrant liabilities | ||||||||
| Deferred underwriting fee payable | ||||||||
| TOTAL LIABILITIES | ||||||||
| Class A common stock subject to possible redemption, 280,000,000 shares authorized; 50,000,000 shares issued and outstanding at $10.11 and $10.00 per share redemption value as of December 31, 2022 and 2021, respectively | ||||||||
| STOCKHOLDERS’ DEFICIT | ||||||||
| Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 12,500,000 shares issued and outstanding as of December 31, 2022 and 2021 | ||||||||
| Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 12,500,000 shares issued and outstanding | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| TOTAL STOCKHOLDERS’ DEFICIT | ||||||||
| TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT |
Loading...
